Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yuzhi Zhixue Granules versus tranexamic acid for abnormal uterine bleeding
ChiCTR2200059418Phase 4Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Yuzhi Zhixue and tranexamic acid in menstrual disorders (2 arms), sponsored by Peking University People's Hospital. Primary endpoints: bleeding volume, bleeding duration and 3 more. Planned start Feb 2022; status: not yet recruiting.
02
Drugs
Yuzhi Zhixuetranexamic acid
03
Conditions
menstrual disorders
Beyond the preview
Go deeper on ChiCTR2200059418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059418.